Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine

Pediatric Infectious Disease Journal

Volumn 17, Issue 8, 1998, Pages 685-691

  Sorensen, Ricardo U ^a   Leiva, Lily E ^a   Giangrosso, Patricia A ^a   Butler, Boyd ^a   Javier III, Felipe C ^a   Sacerdote, Daniela M ^a   Bradford, Nicola ^b   Moore, Cleveland ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Conjugate vaccine; Immunization; Polysaccharide vaccine; Recurrent infections; Streptococcus pneumoniae

Indexed keywords

HEPTAVALENT CONJUGATE STREPTOCOCCUS PNEUMONIAE VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CHILDHOOD DISEASE; DOSE RESPONSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT INFECTION; STREPTOCOCCUS INFECTION;

EID: 0031841825     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199808000-00005     Document Type: Article

References (33)

1. Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 1987; 316:790-3.
2. Hidalgo H, Moore C, Leiva L, Sorensen RU. Pre- and post-pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol 1996;76:341-6.
3. Epstein M, Gruskay F. Selective deficiency in pneumococcal antibody response in children with recurrent infections. Ann Allergy Asthma Immunol 1996;75:125-31.
4. Sorensen RU, Moore C. Immunology in the pediatrician's office. Pediatr Clin North Am 1994;41:691-714.
5. Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunological memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993;169: 663-71.
6. Silverstein AM, Uhr W, Kramer K, Lukes RJ. Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb. J Exp Med 1963;117:799-812.
7. Sniadak DH, Schwartz B, Lipman H, et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children-implications for vaccine strategies. Pediatr Infect Dis J 1995;14:503-10.
8. Ahman H, Kayhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996;15: 134-9.
9. Leach A, Ceesay SJ, Banya WAS, Greenwood BM. Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants. Pediatr Infect Dis J 1996; 15:333-9.
10. Dagan R, Melamed R, Zamir O, Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr Infect Dis J 1997;16:1053-9.
11. Pichichero ME, Shelly MA, Treanor JJ. Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers. Pediatr Infect Dis J 1997;16:72-4.
12. Koskela M. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr Infect Dis J 1987;6:519-26.
13. Quataert SACS, Kirch LJ, Quackenbush DC, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin Diagn Lab Immunol 1995;2:590-2.
14. Summary of the proceedings. WHO Workshop on Pneumococcal ELISA Standardization 1996. Atlanta, GA: Centers for Disease Control and Prevention.
15. Gross S, Blaiss MS, Herrod HG. Role of immunoglobulin subclasses and specific antibody determinations in the evaluation of recurrent infection in children. J Pediatr 1992;121: 516-22.
16. Sanders LA, Rijkers GT, Kuis W, et al. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol 1993;91:110-19.
17. Zora JA, Silk HJ, Tinkelman DG. Evaluation of postimmunization pneumococcal titers in children with recurrent infections and normal levels of immunoglobulin. Ann Allergy 1993;70:283-7.
18. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG-2 concentration and the antibody response to bacterial polysaccharide antigens. N Eng J Med 1980;303:178-82.
19. Barret DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986;63: 127-34.
20. Lortan JE, Kaniuk A, Monteil MA. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin Exp Immunol 1993;91:54-7.
21. Lim PL, Lau YL. Occurrence of IgG subclass antibodies to ovalbumin, avidin, and pneumococcal polysaccharide in children. Int Arch Allergy Immunol 1994;104:137-43.
22. Sorensen RU, Hidalgo H, Moore C, Leiva LE. Antipneumococcal antibody titers and IgG subclasses in children with recurrent respiratory infections. Pediatr Pulmonol 1996; 22:167-73.
23. Sanders LA, Rijkers GT, Tenbergen-Meekes AM, Voorhorst-Ogink MM, Zegers BJ. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections. Pediatr Res 1995;37:812-19.
24. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981;3:S184-97.
25. Lawrence EM, Edwards KM, Schiffmann G, Thompson JM, Vaughn WK, Wright PF. Pneumococcal vaccine in normal children. Am J Dis Child 1983;137:846-50.
26. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8.
27. O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thorns ML, Madore D. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines. Pediatr Infect Dis J 1996;15:425-30.
28. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996;128:649-53.
29. Obaro SK, Huo Z, Banya WAS, et al. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Pediatr Infect Dis J 1997;16:1135-40.
30. King JC, Vink PE, Farley JJ, et al. Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children. Pediatr Infect Dis J 1996;15:192-6.
31. Butler JC, Breiman RF, Lipman HB, Hofman J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995;171:885-9.
32. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:337-82.
33. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995;127: 533-7.